1. Synthesis and anti-Human Immunodeficiency Virus Activity of Substituted (O,O-Difluorophenyl)-linked-pyrimidines as Potent Non-Nucleoside Reverse Transcriptase Inhibitors. Cechova, L., M. Dejmek, O. Baszczynski, D. Saman, L. Gao, E. Hu, G. Stepan, P. Jansa, Z. Janeba, and P. Simon. Antiviral Chemistry & Chemotherapy, 2019. 27(2040206619826265): 18pp. PMID[30788976]. PMCID[PMC6376552].
[PubMed]. HIV_02_2019.
2. Human anti-HIV-1 gp120 Monoclonal Antibodies with Neutralizing Activity Cloned from Humanized Mice Infected with HIV-1. Gawron, M.A., M. Duval, C. Carbone, S. Jaiswal, A. Wallace, J.C. Martin, 3rd, A. Dauphin, M.A. Brehm, D.L. Greiner, L.D. Shultz, J. Luban, and L.A. Cavacini. Journal of Immunology, 2019. 202(3): p. 799-804. PMID[30593536]. PMCID[PMC6344273].
[PubMed]. HIV_02_2019.
3. Exploiting the Tolerant Region I of the Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Binding Pocket: Discovery of Potent Diarylpyrimidine-typed HIV-1 NNRTIs against Wild-type and E138K Mutant Virus with Significantly Improved Water Solubility and Favorable Safety Profiles. Huang, B., W. Chen, T. Zhao, Z. Li, X. Jiang, T. Ginex, D. Vilchez, F.J. Luque, D. Kang, P. Gao, J. Zhang, Y. Tian, D. Daelemans, E. de Clercq, C. Pannecouque, P. Zhan, and X. Liu. Journal of Medicinal Chemistry, 2019. 62(4): p. 2083-2098. PMID[30721060].
[PubMed]. HIV_02_2019.
4. Evaluation of Novel N'-(3-Hydroxybenzoyl)-2-oxo-2H-chromene-3-carbohydrazide Derivatives as Potential HIV-1 Integrase Inhibitors. Jesumoroti, O.J., Faridoon, D. Mnkandhla, M. Isaacs, H.C. Hoppe, and R. Klein. MedChemComm, 2019. 10(1): p. 80-88. PMID[30774857]. PMCID[PMC6350760].
[PubMed]. HIV_02_2019.
5. Synthesis and Biological Evaluation of 3,9-Dioxatetraasteranes as C2-symmetric HIV-1 Protease Inhibitors and Docking Study. Li, P., S. Wang, H. Wang, and H. Yan. Biological and Pharmaceutical Bulletin, 2019. 42(2): p. 261-267. PMID[30713256].
[PubMed]. HIV_02_2019.
6. Anti-HIV-1 Activities and Chemical Constituents from Leaves and Twigs of Santisukia pagetii (Bignoniaceae). Limjiasahapong, S., P. Tuchinda, V. Reutrakul, M. Pohmakotr, R. Akkarawongsapat, J. Limthongkul, C. Napaswad, and N. Nuntasaen. Natural Product Communications, 2018. 13(11): p. 1449-1452. ISI[000456230000009].
[WOS]. HIV_02_2019.
7. Capillasterin A, a Novel Pyrano[2,3-f]chromene from the Australian Crinoid Capillaster multiradiatus. Lum, K.Y., A.R. Carroll, M.G. Ekins, S. Read, Z. Haq, I. Tietjen, J. St John, and R.A. Davis. Marine Drugs, 2019. 17(1): e26. PMID[30621172]. PMCID[PMC6356231].
[PubMed]. HIV_02_2019.
8. Synthesis and anti-HIV Activity of Guanine Modified Fluorinated Acyclic Nucleoside phosphonate Derivatives. Luo, M., E. Groaz, S. De Jonghe, D. Schols, and P. Herdewijn. Chemistry & Biodiversity, 2019. 16(2): e1800532. PMID[30431702].
[PubMed]. HIV_02_2019.
9. Anti HIV-1 Activity, Anti Bacterial Activity and Phytochemical Analysis of Leaf Extracts from Cleistanthus collinus (Roxb.) Benth. ex Hook.f. Mohanraj, R., S. Haidar, M. Nobre, and R. Anantan. Indian Journal of Traditional Knowledge, 2018. 17(4): p. 770-775. ISI[000458093200019].
[WOS]. HIV_02_2019.
10. Aryl Substituted Benzimidazolones as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. Pribut, N., A.E. Basson, W.A.L. van Otterlo, D.C. Liotta, and S.C. Pelly. ACS Medicinal Chemistry Letters, 2019. 10(2): p. 196-202. PMID[30783503]. PMCID[PMC6378675].
[PubMed]. HIV_02_2019.
11. Synthesis of 1',2'-Methano-2',3'-dideoxynucleosides as Potential Antivirals. Rico, L. and S. Hanessian. Bioorganic & Medicinal Chemistry Letters, 2019. 29(4): p. 597-600. PMID[30612845].
[PubMed]. HIV_02_2019.
12. Structural Studies and Biological Evaluation of T30695 Variants Modified with Single Chiral Glycerol-T Reveal the Importance of LEDGF/p75 for the Aptamer anti-HIV-integrase Activities. Rivieccio, E., L. Tartaglione, V. Esposito, C. Dell'Aversano, P.C. Koneru, M. Scuotto, A. Virgilio, L. Mayol, M. Kvaratskhelia, and M. Varra. Biochimica et Biophysica Acta, 2019. 1863(2): p. 351-361. PMID[30414444].
[PubMed]. HIV_02_2019.
13. Aryl H-Phosphonates. 19. New anti-HIV Pronucleotide Phosphoramidate Diesters Containing Amino- and Hydroxypyridine Auxiliaries. Romanowska, J., K. Kolodziej, M. Sobkowski, M. Rachwalak, T. Jakubowski, J. Golebiewska, A. Kraszewski, J. Boryski, A. Dabrowska, and J. Stawinski. European Journal of Medicinal Chemistry, 2019. 164: p. 47-58. PMID[30590257].
[PubMed]. HIV_02_2019.
14. Discovery of 4-Oxoquinolines, a New Chemical Class of anti-HIV-1 Compounds. Shiroishi-Wakatsuki, T., M. Maejima-Kitagawa, A. Hamano, D. Murata, S. Sukegawa, K. Matsuoka, H. Ode, A. Hachiya, M. Imahashi, Y. Yokomaku, N. Nomura, W. Sugiura, and Y. Iwatani. Antiviral Research, 2019. 162: p. 101-109. PMID[30582937].
[PubMed]. HIV_02_2019.
15. Development and Evaluation of Peptide-functionalized Gold Nanoparticles for HIV Integrase Inhibition. Singh, L., H.G. Kruger, G.E.M. Maguire, T. Govender, and R. Parboosing. International Journal of Peptide Research and Therapeutics, 2019. 25(1): p. 311-322. ISI[000457490500031].
[WOS]. HIV_02_2019.
16. Click Chemistry-assisted Synthesis of Novel C-2 Triazole-linked Betulinic acid Conjugates with Azidothymidine as Potential anti-HIV Agents. Spivak, A.Y., D.A. Nedopekina, Z.R. Galimshina, R.R. Khalitova, Z.R. Sadretdinova, R.R. Gubaidullin, and V.N. Odinokov. Arkivoc, 2018: p. 1-19. ISI[000456187500001].
[WOS]. HIV_02_2019.
17. Pharmacophore-based Design of Novel 3-Hydroxypyrimidine-2,4-dione Subtypes as Inhibitors of HIV Reverse Transcriptase-associated RNase H: Tolerance of a Nonflexible Linker. Tang, J., H.T. Do, A.D. Huber, M.C. Casey, K.A. Kirby, D.J. Wilson, J. Kankanala, M.A. Parniak, S.G. Sarafianos, and Z. Wang. European Journal of Medicinal Chemistry, 2019. 166: p. 390-399. PMID[30739822].
[PubMed]. HIV_02_2019.
18. An Isoquinoline Scaffold as a Novel Class of Allosteric HIV-1 Integrase Inhibitors. Wilson, T.A., P.C. Koneru, S.V. Rebensburg, J.J. Lindenberger, M.J. Kobe, N.T. Cockroft, D. Adu-Ampratwum, R.C. Larue, M. Kvaratskhelia, and J.R. Fuchs. ACS Medicinal Chemistry Letters, 2019. 10(2): p. 215-220. PMID[30783506]. PMCID[PMC6378678].
[PubMed]. HIV_02_2019.
19. Antifungal Proteins with Antiproliferative Activity on Cancer Cells and HIV-1 Enzyme Inhibitory Activity from Medicinal Plants and Medicinal Fungi. Wong, J.H., T.B. Ng, H. Wang, R.C.F. Cheung, C.C.W. Ng, X. Ye, J. Yang, F. Liu, C. Ling, K. Chan, X. Ye, and W.Y. Chan. Current Protein & Peptide Science, 2019. 20(3): p. 265-276. PMID[29895244].
[PubMed]. HIV_02_2019.
20. Discovery and Synthesis of Novel Beesioside I Derivatives with Potent anti-HIV Activity. Wu, H., G. Ma, Q. Yang, Y. Zhu, L. Huang, Y. Tian, X. Yang, M. Zhang, C.H. Chen, S.L. Morris-Natschke, M. Yang, X. Xu, and K.H. Lee. European Journal of Medicinal Chemistry, 2019. 166: p. 159-166. PMID[30703659].
[PubMed]. HIV_02_2019.
21. 3,4-Seco-norclerodane Diterpenoids from the Roots of Polyalthia laui. Yu, Z.X., C.J. Zheng, G.Y. Chen, R.L. Huang, X.M. Zhou, Z.G. Niu, X.B. Li, C.R. Han, and X.P. Song. Journal of Natural Products, 2019. 82(1): p. 27-34. PMID[30596489].
[PubMed]. HIV_02_2019.
22. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV. Zhang, Y., J.H. Chapman, A. Ulcay, and R.E. Sutton. Journal of Virology, 2019. 93(4): e01446-01418. PMID[30518644]. PMCID[PMC6363990].
[PubMed]. HIV_02_2019.
23. Design, Synthesis and Biological Evaluation of Novel HIV-1 Protease Inhibitors with Pentacyclic triterpenoids as P2-ligands. Zhu, M., X.N. Du, Y.G. Li, G.N. Zhang, J.X. Wang, and Y.C. Wang. Bioorganic & Medicinal Chemistry Letters, 2019. 29(3): p. 357-361. PMID[30580917].
[PubMed]. HIV_02_2019.
Patent Citations
24. Preparation of Hydrazide Compounds for Treating Antibacterial, Antifungal and Antiviral Infections.Hernandez Cabanillas, A., S. Maderuelo Corral, M. Ortega Domenech, D.F. Rosero Valencia, A. Rumbero Sanchez, and V. Tena Perez. Patent. 2019. 2018-EP70700 2019025426: 109pp.
[Patent]. HIV_02_2019.